Maintaining the identity of acinar cells in the pancreas could help to prevent the development of pancreatic cancer.
Pancreatic cancer is the fourth most common cause of cancer-related death in the United States, with only 6% of people surviving for five years after diagnosis. Now, in eLife, Charles Murtaugh and co-workers – including Nathan Krah as first author – shed new light on the process that leads normal pancreatic cells to become cancer cells (Krah et al., 2015).
The exocrine pancreas is the part of the pancreas that produces the enzymes that help to digest food, and is also the region where pancreatic cancer arises. It remains unclear how normal exocrine cells – two types of which are the acinar and ductal cells – become cancerous. Pancreatic cancer – as well as the pre-cancerous lesions that precede it – consists of cells that resemble ductal cells. It had thus been assumed that ductal cells are the origin of this disease. However, this notion has been challenged by recent experimental evidence from genetically engineered mice that suggests that acinar cells are in fact the most common source of pancreatic cancer (for review see Puri et al., 2015).
For acinar cells to give rise to cancer, they first must lose their acinar characteristics and become duct-like, in a process known as acinar-to-ductal metaplasia (or ADM). Then, these duct-like cells transform into cancer precursor cells and, in time, become cancer cells. This cancerous transformation is associated with the presence of a form of the Kras gene that causes cells to divide more often (known as the Kras oncogene). Experimentally, the transformation of the duct-like cells into a cancerous form is modelled in mice that are engineered to express the Kras oncogene. These mice develop small pre-cancerous lesions in their pancreas that only arise from a small subset of the acinar cells, despite mutant Kras expression in all cells.
Krah et al. – who are based at the University of Utah, Vanderbilt Medical Center and University of Texas Southwestern Medical Center – sought to determine what normally protects against the Kras-mediated transformation in acinar cells; that is to say, the safety mechanisms that are bypassed during the formation of pre-cancerous lesions.
Since the first step of pancreatic cancer development is the ADM process that causes the acinar cells to become duct-like, Krah et al. hypothesized that preventing ADM from occurring may protect against Kras-mediated transformation. They reasoned that PTF1A, a protein that regulates the differentiation of acinar cells from precursor cells during pancreas development is similarly required to maintain the identity of the acinar cells in the adult pancreas. Thus, PTF1A could protect against the Kras-mediated transformation of the cells to a pre-cancerous cell type by preventing ADM. This hypothesis was based on previous studies of other molecules that regulate differentiation and guide the development of acinar cells, because these so-called “acinar differentiation factors” have been seen to protect against Kras-mediated transformation. Furthermore, inactivating these differentiation factors promotes the ADM process (Shi et al., 2009; von Figura et al., 2014).
To investigate the role of PTF1A, Krah et al. first examined when and where this protein was expressed throughout the pancreas. This revealed that PTF1A is not produced in the pre-cancerous lesions of either humans or mice. However, PTF1A was expressed in adjacent acinar cells that appeared normal, suggesting that PTF1A may protect against Kras-mediated transformation in these cells.
Next, Krah et al. used genetic mouse models to prevent acinar cells from producing PTF1A, and observed spontaneous ADM in these animals. Expressing the Kras oncogene in these mice caused precursor lesions to form more rapidly and over a wider area of the pancreas than those seen in mice whose acinar cells expressed both PTF1A and oncogenic Kras. Together, these data show that acinar cells must lose PTF1A before they can undergo ADM, and thus become susceptible to Kras-induced transformation.
Furthermore, by gene expression analysis, Krah et al. showed that PTF1A controls multiple genes and pathways associated with both the initiation of pancreatic cancer and their continuous need for oncogenic Kras expression.
Overall, Krah et al.'s data show that acinar cell differentiation, which is maintained by PTF1A, protects against the expression of oncogenic Kras and helps to prevent the cells from becoming cancerous. The next open question is whether forced expression of PTF1A in the pancreas protects against Kras-induced transformation; this has already been shown to be the case for a different acinar cell factor called Mist1 (Direnzo et al., 2012). Further open questions include what it is that causes the accelerated rate at which ADM progresses to precursor lesions in mice that express oncogenic Kras and lack PTF1A (compared with mice that do express PTF1A). Since PTF1A is normally lost during the process of ADM, the absence of this protein cannot explain the accelerated rate of cancer progression. It is possible that in mice that carry oncogenic Kras and still retain intact PTF1A, an equilibrium between acinar cells and ADM cells occurs, whereby ADM cells can ‘choose’ to re-express PTF1A and return to an acinar fate, or progress to form pre-cancerous lesions (Figure 1). This equilibrium would be lost in mice lacking PTF1A, where cells that have undergone ADM have no choice other than to progress towards becoming cancerous. Furthermore, the effect PTF1A re-expression has in pre-cancerous lesions as well as in advanced disease merits further exploration.
In summary, this study provides new insight into the process that triggers the development of pancreatic cancer. In doing so, it opens many avenues of exploration that will provide more insight into the biology of this disease – an essential first step towards developing new therapies.
- Version of Record published: August 14, 2015 (version 1)
© 2015, Schofield and Pasca di Magliano
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
SOX11 is an embryonic mammary epithelial marker that is normally silenced prior to birth. High SOX11 levels in breast tumours are significantly associated with distant metastasis and poor outcome in breast cancer patients. Here, we show that SOX11 confers distinct features to ER-negative DCIS.com breast cancer cells, leading to populations enriched with highly plastic hybrid epithelial/mesenchymal cells, which display invasive features and alterations in metastatic tropism when xenografted into mice. We found that SOX11+DCIS tumour cells metastasize to brain and bone at greater frequency and to lungs at lower frequency compared to cells with lower SOX11 levels. High levels of SOX11 leads to the expression of markers associated with mesenchymal state and embryonic cellular phenotypes. Our results suggest that SOX11 may be a potential biomarker for breast tumours with elevated risk of developing metastases and may require more aggressive therapies.
Biological tubes must develop and maintain their proper diameter in order to transport materials efficiently. These tubes are molded and protected in part by apical extracellular matrices (aECMs) that line their lumens. Despite their importance, aECMs are difficult to image in vivo and therefore poorly understood. The C. elegans vulva has been a paradigm for understanding many aspects of organogenesis. Here we describe the vulva luminal matrix, which contains chondroitin proteoglycans, Zona Pellucida (ZP) domain proteins, and other glycoproteins and lipid transporters related to those in mammals. Confocal and transmission electron microscopy revealed, with unprecedented detail, a complex and dynamic aECM. Different matrix factors assemble on the apical surfaces of each vulva cell type, with clear distinctions seen between Ras-dependent (1˚) and Notch-dependent (2˚) cell types. Genetic perturbations suggest that chondroitin and other aECM factors together generate a structured scaffold that both expands and constricts lumen shape.